Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular characterization and genotyping of isolates from cancer patients with Clostridioides difficile infection or asymptomatic colonization.
de-la-Rosa-Martinez D, Bobadilla Del Valle M, Esteban-Kenel V, Zinser Peniche P, Ponce De León Garduño A, Cornejo Juárez P, Sánchez Cruz MN, Camacho-Ortiz A, Vilar-Compte D. de-la-Rosa-Martinez D, et al. Among authors: camacho ortiz a. J Med Microbiol. 2023 Aug;72(8). doi: 10.1099/jmm.0.001748. J Med Microbiol. 2023. PMID: 37624363
Correction: First Report of Clostridium difficile NAP1/027 in a Mexican Hospital.
Camacho-Ortiz A, López-Barrera D, Hernández-García R, Galván-De los Santos AM, Flores-Treviño SM, Llaca-Díaz JM, Maldonado-Garza HJ, Bosques-Padilla FJ, Garza-González E. Camacho-Ortiz A, et al. PLoS One. 2015 May 28;10(5):e0129079. doi: 10.1371/journal.pone.0129079. eCollection 2015. PLoS One. 2015. PMID: 26020926 Free PMC article. No abstract available.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group. Marconi VC, et al. Lancet Respir Med. 2021 Dec;9(12):1407-1418. doi: 10.1016/S2213-2600(21)00331-3. Epub 2021 Sep 1. Lancet Respir Med. 2021. PMID: 34480861 Free PMC article. Clinical Trial.
Isolation of carbapenem-resistant NDM-1-positive Providencia rettgeri in Mexico.
Barrios H, Garza-Ramos U, Reyna-Flores F, Sanchez-Perez A, Rojas-Moreno T, Garza-Gonzalez E, Llaca-Diaz JM, Camacho-Ortiz A, Guzmán-López S, Silva-Sanchez J. Barrios H, et al. J Antimicrob Chemother. 2013 Aug;68(8):1934-6. doi: 10.1093/jac/dkt124. Epub 2013 Apr 25. J Antimicrob Chemother. 2013. PMID: 23620464 No abstract available.
Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity.
Flores-Treviño S, Gutiérrez-Ferman JL, Morfín-Otero R, Rodríguez-Noriega E, Estrada-Rivadeneyra D, Rivas-Morales C, Llaca-Díaz JM, Camacho-Ortíz A, Mendoza-Olazarán S, Garza-González E. Flores-Treviño S, et al. J Med Microbiol. 2014 Nov;63(Pt 11):1524-1530. doi: 10.1099/jmm.0.074385-0. Epub 2014 Aug 27. J Med Microbiol. 2014. PMID: 25165124
First report of Clostridium difficile NAP1/027 in a Mexican hospital.
Camacho-Ortiz A, López-Barrera D, Hernández-García R, Galván-De Los Santos AM, Flores-Treviño SM, Llaca-Díaz JM, Maldonado-Garza HJ, Bosques-Padilla FJ, Garza-González E. Camacho-Ortiz A, et al. PLoS One. 2015 Apr 27;10(4):e0122627. doi: 10.1371/journal.pone.0122627. eCollection 2015. PLoS One. 2015. PMID: 25915544 Free PMC article.
144 results